The World Health Organization's chief scientist said in June that the vaccine was probably the most advanced in terms of development.
The Lancet's statement came after reports earlier on Wednesday that the Phase I data could be released as soon Thursday.
Developers of the vaccine, known as known as AZD1222, said earlier this month they were encouraged by the immune response they had seen in trials so far and were expecting to publish Phase I data by the end of July. A preclinical trial of the shot in pigs showed that two doses produced a greater antibody response than a single dose.
More than 100 vaccines are being developed and tested around the world to try to stop the COVID-19 pandemic, which has killed hundreds of thousands and ravaged the global economy.The World Health Organization's chief scientist said in June that AstraZeneca's AZD1222 was probably the most advanced in terms of development.
The company has signed agreements with governments around the globe to supply the vaccine should it prove effective.on Tuesday that Moderna, Inc.'s experimental vaccine showed it was safe and provoked immune responses in all 45 healthy volunteers in an ongoing early-stage study.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Early-stage trial data on AstraZeneca COVID-19 vaccine due July 20 - LancetThe Lancet medical journal said on Wednesday it will publish keenly-awaited phase 1 clinical trial data on a potential COVID-19 vaccine being developed by Astrazeneca and Oxford University on Monday.
Weiterlesen »
Potential COVID-19 vaccine shows promise in early trial'It is good news that it's not bad news,' infectious disease expert Dr. Michael Osterholm says about promising results from Moderna's first COVID-19 vaccine trial. 'But remember, we're in the first 100 yards of a marathon.'
Weiterlesen »
Early-stage trial data on AstraZeneca COVID-19 vaccine due Monday - LancetEarly-stage human trial data on a vaccine being developed by AstraZeneca and Oxford University will be published on July 20, The Lancet medical journal said on Wednesday.
Weiterlesen »
Moderna expects to start late-stage COVID-19 vaccine trial on July 27Moderna Inc said on Tuesday it plans to start a late stage clinical trial for its COVID-19 vaccine candidate on or around July 27, according to its listing for the phase 3 study at clinicaltrials.gov.
Weiterlesen »
Trump's ex-chief of staff Mick Mulvaney says U.S. has 'inexcusable' problems with COVID-19 testingMulvaney described his family's efforts to get tested for the coronavirus, noting that they had to wait up to a week to receive his son's results, while being told his daughter didn't meet the criteria for receiving a test.
Weiterlesen »
Subways sparkle, but does cleaning decrease COVID-19 risk?Robust scrubbing by mass transit workers is producing something commuters rarely see: subway cars that look, feel and even smell clean. Such measures cut the threat of catching the coronavirus, experts say - but maybe not as much as you'd think.
Weiterlesen »